Hearing device
decision helper

Method notes

What this decision helper does

This page turns a small set of hearing device questions into a plain-language pathway. It asks about age, warning signs, the degree of hearing loss you know or suspect, whether you need an in-person fitting, your budget priority, and tinnitus. Each result explains the reason for the path. The logic is based on the U.S. Food and Drug Administration's 2022 over-the-counter hearing aid rule and guidance from the National Institute on Deafness and Other Communication Disorders.

The helper is not a hearing test and does not examine the ear. It cannot tell whether your hearing loss is conductive, sensorineural, mixed, temporary, or permanent. It cannot decide whether amplification is appropriate for a particular ear. It is a way to organize the questions that should come before a device decision, especially when a direct-to-consumer route seems attractive but the underlying hearing picture is not clear.

The result is deliberately a pathway rather than a product name. An OTC hearing aid, a prescription hearing aid, a PSAP, and a clinician visit serve different purposes. The right category depends on age, the type and degree of hearing difficulty, the need for fitting or follow-up, and the presence of symptoms that need examination. Budget is included because it is part of a real decision, but it does not override safety or fit.

What the FDA changed in 2022

The FDA established a regulatory category for OTC hearing aids in a final rule published in August 2022. The rule took effect on October 17, 2022. This category applies to air-conduction hearing aids intended for adults 18 years and older with perceived mild to moderate hearing loss. A person in that group can buy a qualifying OTC hearing aid without a medical exam, prescription, or professional fitting being required for the sale.

What OTC means here

OTC does not mean that every amplifier is an OTC hearing aid. The category has a defined intended user and device requirements. FDA labeling includes signs that suggest mild to moderate hearing loss, signs that call for a hearing professional, and warnings about symptoms such as sudden hearing change, ear pain, ear drainage, one-sided hearing difference, and vertigo with hearing loss. The rule also includes requirements for user-adjustable volume control, output limits, insertion depth, and package information.

A qualifying OTC hearing aid is designed for an adult who perceives mild to moderate hearing difficulty. It is not the general category for a child, a person with severe or profound hearing loss, or a person whose symptoms suggest an ear problem that needs medical review. The sale route does not remove the need for clinical care when warning signs are present.

How NIDCD separates the device paths

NIDCD describes OTC hearing aids as devices for adults with perceived mild to moderate hearing loss. It describes prescription hearing aids as devices available through hearing health professionals and suitable for a wider range of hearing loss and ages, based on the device's intended use. Prescription care can include a hearing test, device selection, programming, adjustments, and follow-up. The helper sends people toward that route when those elements are part of the need.

NIDCD also distinguishes personal sound amplification products, or PSAPs, from hearing aids. A PSAP is intended for people without hearing loss who want to hear particular environmental sounds, such as while bird-watching. It is not regulated as a medical device for hearing loss. Calling a product an amplifier does not make it a hearing aid, and a PSAP does not answer a broad concern about hearing speech in daily life.

Why the category matters

The category tells you what the device is intended to do. It does not provide a personal recommendation. Two adults can both report mild to moderate hearing difficulty but have different needs for directionality, telephone use, manual controls, connectivity, physical comfort, or support. A person with tinnitus may also need a separate discussion about the sound, hearing asymmetry, balance, and the timing of symptoms.

Why each question changes the path

Age

The OTC category is for adults 18 years and older. The FDA warning information directs people younger than 18 toward a doctor, preferably an ENT doctor, because children and teenagers need age-specific assessment. The helper therefore sends an under-18 answer to the prescription and clinician pathway. It does not attempt to apply an adult category to a child.

Warning signs

Ear pain, drainage, blood or pus, sudden or quickly worsening hearing change, one-sided hearing difference, one-sided tinnitus, excessive wax or a suspected object, and vertigo with hearing loss can point to a problem that needs assessment. An amplifier may make sound louder while leaving the cause unexamined. The helper sends a yes answer to a clinician-first result so an audiologist, ENT doctor, or other clinician can decide what examination is needed.

Degree of hearing loss

Perceived mild to moderate hearing loss is the adult group named by the FDA OTC category. If the loss is severe or profound, NIDCD says an OTC device may not provide enough amplification, so the helper points to prescription care. If you do not know the degree, the helper points to an audiologist first. A hearing test gives the clinician information that a self-description cannot provide.

Fitting and programming

Some people want to place, adjust, and learn a device on their own. Others need a professional to select settings, make physical adjustments, or provide follow-up. The FDA category allows self-fitting or self-adjusted OTC devices, but it does not require every person to use that route. If in-person fitting or individual programming is central to your need, the helper points to a prescription or clinician-led pathway.

Budget and tinnitus

Budget can help a person choose what to investigate first, but a lower upfront route is not automatically the right route. The degree of hearing loss, the need for fitting, and the warning signs still control the main branch. Tinnitus also does not establish a device category. When tinnitus is present, note whether it is new, one-sided, pulsatile, or linked to a hearing change. Those details may change the urgency of clinical assessment.

Limits of this decision tree

The helper uses the answers you enter and the rules described in the cited guidance. It does not check a device label, confirm that a named product belongs to the OTC category, compare features, or review a seller's terms. It does not know your country or local regulations. The FDA rule is U.S. guidance, so local rules may differ elsewhere.

The phrase perceived mild to moderate hearing loss is important. The rule does not require a measurement before an adult buys an OTC hearing aid, but a hearing examination can still be useful. If speech is difficult to hear even in a quiet room, loud sounds are difficult to hear, hearing changes over time, or one ear differs from the other, a hearing professional can help determine whether an OTC device fits the actual problem.

A device cannot explain ear pain, discharge, a foreign object, a sudden hearing change, facial weakness, or dizziness paired with hearing change. These features need a clinician. If symptoms are severe or rapidly changing, use local urgent care instructions rather than relying on this page.

Questions to ask before a device decision

Start by separating the hearing question from the shopping question. Ask whether the difficulty is gradual or sudden, whether it affects one ear or both, whether speech is difficult in quiet, and whether loud sounds are also hard to hear. Ask whether the ear feels painful or blocked, whether there is discharge, and whether tinnitus or dizziness appeared at the same time. These details can move the decision from device selection to medical assessment.

Questions about an OTC hearing aid

Read the outside package before buying. Check that it says OTC hearing aid and that the intended user is an adult with perceived mild to moderate hearing loss. Review the warnings, maximum output information, volume control, battery or charging details, whether a phone is needed, and the manufacturer's current support terms. The FDA requires information that helps a consumer recognize when professional care may be needed. A label is useful evidence about the category, but it does not replace a hearing test.

Questions about prescription care

Ask an audiologist what the hearing test shows in each ear, which listening situations are hardest, how the device will be programmed, what follow-up is available, and which controls you can use yourself. Ask how the device will be adjusted if speech remains unclear or if sound is uncomfortable. If tinnitus is present, ask how it should be assessed separately from the hearing loss. An otolaryngologist can review medical findings when pain, drainage, asymmetry, sudden change, or balance symptoms are part of the story.

Questions about a PSAP

If you do not have known hearing loss and want help in one defined situation, identify the situation clearly. A PSAP is a situational amplifier, not a replacement for a hearing aid or hearing assessment. If you need help in conversations, on the phone, in quiet, or across many settings, ask for a hearing evaluation rather than assuming a situational product answers the broader concern.

Keep a short record of what you notice after any device decision. Note the listening setting, whether speech is clearer, whether the device feels comfortable, and whether tinnitus, pain, or dizziness changes. If the device does not meet the need, take the record to the audiologist or prescriber. The record can describe the problem without turning it into a claim about a particular product.

Questions readers ask

Sources

• FDA, OTC Hearing Aids: What You Should Know.
• Federal Register, Establishing Over-the-Counter Hearing Aids, 2022.
• NIDCD, Over-the-Counter Hearing Aids.
• NIDCD, Hearing Aids.